WHO ICTRP trial
Investigation of the antiviral effect of Voclosporine on COVID-19 in renal…
EUCTR2020-001467-82-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-001467-82-NL |
|---|---|
| Public title | Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients |
| Scientific title | An Open-Label Study Evaluating Anti-Viral Effects of Voclosporin in SARS-CoV-2 Positive Kidney Transplant Recipients – the VOCOVID Study (COVID-19) - The VOCOVID Study |
| Primary sponsor | Leiden University Medical Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | SARS-CoV-2 infection in Kidney Transplant Recipients MedDRA version: 23.0 Level: PT Classification code 10051905 Term: Coronavirus infection System Organ Class: 10021881 - Infections and infestations MedDRA version: 21.1 Level: LLT… |
| Interventions | Product Name: Voclosporin or Lupkynis Pharmaceutical Form: Capsule, soft INN or Proposed INN: Voclosporin CAS Number: 515814-01-4 Current Sponsor code: ISA247 Other descriptive name: VOCLOSPORIN Concentration unit: mg milligram(s)… |
| Registration date | Apr 28, 2020 |
| Target size | 30 |
| Secondary IDs | P020.051 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: